OR WAIT null SECS
June 08, 2016
The agency cited KO DA Pharmaceutical Co. with cGMP violations.
June 01, 2016
FDA issues a warning letter to Megafine Pharma Limited for data integrity violations.
May 31, 2016
The company received a warning letter at its Latina facility in Sermoneta, Italy following a May 2015 inspection.
May 26, 2016
The agency cited Tai Heng Industry with CGMP deviations, including failure to ensure data integrity.
May 24, 2016
FDA cited BBT Biotech GMBH for failing to comply with current good manufacturing practice in its German API manufacturing facility.
May 10, 2016
The agency cited Apotheca Supply, a repackager and relabeler of pharmaceuticals for CGMP violations.
May 03, 2016
A federal judge entered an order of permanent injunction against Paul W. Franck, the owner and operator of several compounding pharmacies in Florida.
April 18, 2016
The agency published guidance on data integrity as it is relates to CGMP compliance.
March 18, 2016
The agency cited Emcure Pharmaceuticals with CGMP violations.
March 03, 2016
The inspection confirmed that the facility was compliant with GMP guidelines.